Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 12beta-isomer Deoxycholic Acid
2. 3beta-isomer Deoxycholic Acid
3. 5alpha-isomer Deoxycholic Acid
4. Choleic Acid
5. Deoxycholate
6. Deoxycholate, Sodium
7. Deoxycholic Acid
8. Deoxycholic Acid, 12beta Isomer
9. Deoxycholic Acid, 12beta-isomer
10. Deoxycholic Acid, 3beta Isomer
11. Deoxycholic Acid, 3beta-isomer
12. Deoxycholic Acid, 5alpha Isomer
13. Deoxycholic Acid, 5alpha-isomer
14. Deoxycholic Acid, Disodium Salt
15. Deoxycholic Acid, Magnesium (2:1) Salt
16. Deoxycholic Acid, Monoammonium Salt
17. Deoxycholic Acid, Monopotassium Salt
18. Deoxycholic Acid, Monosodium Salt
19. Deoxycholic Acid, Sodium Salt, 12beta-isomer
20. Desoxycholic Acid
21. Dihydroxycholanoic Acid
22. Kybella
23. Lagodeoxycholic Acid
1. 302-95-4
2. Deoxycholic Acid Sodium Salt
3. Sodium Desoxycholate
4. Deoxycholate Sodium
5. Desoxycholate Sodium
6. Sodium 7-deoxycholate
7. Sodium Deoxycholic Acid
8. Deoxycholic Acid, Sodium Salt
9. Chebi:9177
10. 3-alpha,12-alpha-dihydroxy-5-beta-cholan-24-oic Acid Sodium Salt
11. 436ls6u35y
12. Kybella
13. Ncgc00091038-01
14. Atx 101
15. Cholan-24-oic Acid, 3,12-dihydroxy-, Monosodium Salt, (3a,5b,12a)-
16. Dsstox_cid_13389
17. Dsstox_rid_79069
18. Dsstox_gsid_33389
19. Na-desoxycholat
20. Mfcd00064139
21. Na-desoxycholat [german]
22. Sodiumdeoxycholate
23. 3,12-dihydroxy-cholan-24-oic Acid Monosodium Salt, (3-alpha,5-beta,12-alpha)- (9ci)
24. Cas-302-95-4
25. Sodium (4r)-4-[(3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoate
26. Ccris 655
27. Einecs 206-132-7
28. Sodium (3alpha,5beta,12alpha)-3,12-dihydroxycholan-24-oate
29. Dihydroxy 3-12 Cholanate De Na [french]
30. Unii-436ls6u35y
31. Dihydroxy 3-12 Cholanate De Na
32. Natrium-3-alpha,12-alpha-dihydroxycholanat [german]
33. Deoxycholic Acid Sodium
34. Sodium 3-alpha,12-alpha-dihydroxy-5-beta-cholan-24-oate
35. Natrium-3-alpha,12-alpha-dihydroxycholanat
36. Schembl37482
37. Mls002695906
38. Chembl1365278
39. Dtxsid5033389
40. Hy-n0593a
41. Sodium Desoxycholate [ii]
42. Sodium Deoxycholate [inci]
43. Tox21_111066
44. Tox21_200896
45. 5-beta-cholan-24-oic Acid, 3-alpha,12-alpha-dihydroxy-, Sodium Salt
46. Akos002391107
47. Akos017345123
48. Cs-8046
49. Nsc 681065
50. 3,12-dihydroxy-cholan-24-oic Acid Monosodium Salt, (3-alpha,5-beta,12-alpha)-
51. Cholan-24-oic Acid, 3,12-dihydroxy-, Monosodium Salt, (3-alpha,5-beta,12-alpha)-
52. Cholan-24-oic Acid, 3,12-dihydroxy-, Monosodium Salt, (3alpha,5beta,12alpha)-
53. Ncgc00258450-01
54. Ac-24206
55. Bp-31018
56. Smr001562102
57. Sodium Deoxycholate, >=97% (titration)
58. Deoxycholic Acid Sodium Salt, For Electrophoresis
59. Q-200935
60. Q25474151
61. Sodium 3alpha,12alpha-dihydroxy-5beta-cholan-24-oate
62. Sodium Deoxycholate, Vetec(tm) Reagent Grade, >=97%
63. Sodium Deoxycholate, Bioxtra, >=98.0% (dry Matter, Nt)
64. 3-.alpha.,12-.alpha.-dihydroxy-5-.beta.-cholan-24-oic Acid Sodium Salt
65. Sodium Deoxycholate, Suitable For Manufacturing Of Diagnostic Kits And Reagents
66. Sodium Deoxycholate, Pharmagrade, Manufactured Under Appropriate Controls For Use As A Raw Material In Pharma Or Biopharmaceutical Production
67. Sodium;(4r)-4-[(3r,5r,10s,12s,13r,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoate
68. Sodium;(4r)-4-[(3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoate
Molecular Weight | 414.6 g/mol |
---|---|
Molecular Formula | C24H39NaO4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 414.27460400 g/mol |
Monoisotopic Mass | 414.27460400 g/mol |
Topological Polar Surface Area | 80.6 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 612 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Cholagogues and Choleretics
Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
27
PharmaCompass offers a list of Sodium Deoxycholate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Deoxycholate manufacturer or Sodium Deoxycholate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Deoxycholate manufacturer or Sodium Deoxycholate supplier.
PharmaCompass also assists you with knowing the Sodium Deoxycholate API Price utilized in the formulation of products. Sodium Deoxycholate API Price is not always fixed or binding as the Sodium Deoxycholate Price is obtained through a variety of data sources. The Sodium Deoxycholate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 83-44-3 (Parent) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 83-44-3 (Parent), including repackagers and relabelers. The FDA regulates 83-44-3 (Parent) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 83-44-3 (Parent) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 83-44-3 (Parent) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 83-44-3 (Parent) supplier is an individual or a company that provides 83-44-3 (Parent) active pharmaceutical ingredient (API) or 83-44-3 (Parent) finished formulations upon request. The 83-44-3 (Parent) suppliers may include 83-44-3 (Parent) API manufacturers, exporters, distributors and traders.
click here to find a list of 83-44-3 (Parent) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 83-44-3 (Parent) DMF (Drug Master File) is a document detailing the whole manufacturing process of 83-44-3 (Parent) active pharmaceutical ingredient (API) in detail. Different forms of 83-44-3 (Parent) DMFs exist exist since differing nations have different regulations, such as 83-44-3 (Parent) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 83-44-3 (Parent) DMF submitted to regulatory agencies in the US is known as a USDMF. 83-44-3 (Parent) USDMF includes data on 83-44-3 (Parent)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 83-44-3 (Parent) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 83-44-3 (Parent) suppliers with USDMF on PharmaCompass.
A 83-44-3 (Parent) CEP of the European Pharmacopoeia monograph is often referred to as a 83-44-3 (Parent) Certificate of Suitability (COS). The purpose of a 83-44-3 (Parent) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 83-44-3 (Parent) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 83-44-3 (Parent) to their clients by showing that a 83-44-3 (Parent) CEP has been issued for it. The manufacturer submits a 83-44-3 (Parent) CEP (COS) as part of the market authorization procedure, and it takes on the role of a 83-44-3 (Parent) CEP holder for the record. Additionally, the data presented in the 83-44-3 (Parent) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 83-44-3 (Parent) DMF.
A 83-44-3 (Parent) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 83-44-3 (Parent) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 83-44-3 (Parent) suppliers with CEP (COS) on PharmaCompass.
83-44-3 (Parent) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 83-44-3 (Parent) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 83-44-3 (Parent) GMP manufacturer or 83-44-3 (Parent) GMP API supplier for your needs.
A 83-44-3 (Parent) CoA (Certificate of Analysis) is a formal document that attests to 83-44-3 (Parent)'s compliance with 83-44-3 (Parent) specifications and serves as a tool for batch-level quality control.
83-44-3 (Parent) CoA mostly includes findings from lab analyses of a specific batch. For each 83-44-3 (Parent) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
83-44-3 (Parent) may be tested according to a variety of international standards, such as European Pharmacopoeia (83-44-3 (Parent) EP), 83-44-3 (Parent) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (83-44-3 (Parent) USP).